KELSEY ELLENDER-BARTHEL: Open Payments
NPI 1629552625 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 10 payments from 8 companies in 2025. Trend: 2023 $1,418 · 2024 $740 · 2025 $317
Food & beverage: $282Education: $35
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $104 |
| AstraZeneca Pharmaceuticals LP | 3 | $81 |
| Dendreon Pharmaceuticals LLC | 1 | $33 |
| Ambu Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Intracept, LYNPARZA, IMFINZI, PROVENGE, QULIPTA, JOURNAVX, INCEPTIV, Nubeqa.
Industry payments across LA — which companies pay providers there.
